胡卜素与PCSK9的相互作用:探索新的降胆固醇策略
Alessandro Medoro1, Giovanni Scapagnini1, Simone Brogi2
1Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.
Pharmaceuticals (Basel, Switzerland)
|January 8, 2025
概括
绿藻类的胡卜素,如阿斯塔桑丁,显示作为PCSK9的天然抑制剂的承诺,PCSK9是一种与高胆固醇和心血管疾病风险相关的蛋白质. 需要进一步的研究来确认它们的治疗潜力.
科学领域:
- 生物化学和分子生物学
- 自然产品化学 自然产品化学
- 心血管药理学心血管药理学
背景情况:
- 蛋白转化酶亚素/素9型 (PCSK9) 通过降解低密度脂蛋白受体 (LDLR) 调节胆固醇代谢.
- 增加PCSK9活性会增加血液中的胆固醇和心血管疾病 (CVD) 的风险.
- 正在探索天然化合物作为胆固醇管理的替代治疗剂.
研究的目的:
- 调查绿藻衍生的胡卜素作为PCSK9.9的潜在天然抑制剂.
- 评估选择的胡卜素与PCSK9.9的结合亲和力和分子相互作用.
- 评估胡卜素在控制胆固醇水平和降低心血管疾病风险方面的治疗潜力.
主要方法:
- 在27种胡卜素的in silico选中,针对PCSK9.9的药理合适度得分进行了选.
- 对排名最高的胡卜素的结合亲和力和分子相互作用的分析.
- 密度函数理论 (DFT) 和分子动力学 (MD) 对阿斯塔克桑-PCSK9复合物的模拟.
主要成果:
- 十四种胡卜素显示出潜在的潜力,其中阿斯塔桑丁,西福纳桑丁和普拉西诺桑丁被确定为最佳候选物质.
- 阿斯塔丁表现出强大的结合亲和力 (-10.5Kcal/mol) 和与关键PCSK9活性部位残留物稳定的相互作用.
- DFT和MD模拟证实了阿斯塔丁的稳定性和有利的电子特性,表明有效的PCSK9抑制.
结论:
- 绿藻类的胡卜素,特别是阿斯塔丁,是现有的PCSK9抑制剂的潜在的经济有效的天然替代品.
- 这些发现表明一种新的方法来控制胆固醇和降低心血管风险.
- 临床前和临床研究是必要的,以验证这些胡卜素的治疗疗效.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
529
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
529
Cholesterol: Significance and Regulation
500
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
500
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
135
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
135


